ArticleJournal of imaging2025
Evolutionary-Driven Convolutional Deep Belief Network for the Classification of Macular Edema in Retinal Fundus Images.
Article in Journal of imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An intensity-aware vision transformer framework for precise localization of vitreous hemorrhage in fundus imaging.International ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early detection of diabetic retinopathy is critical for preserving vision in diabetic patients. The classification of lesions in Retinal fundus images, particularly macular edema, is an essential diagnostic tool, yet it presents a significant learning curve for both novice and experienced ophthalmologists. To address this challenge, a novel Convolutional Deep Belief Network (CDBN) is proposed to classify image patches into three distinct categories: two types of macular edema-microhemorrhages and hard exudates-and a healthy category. The method leverages high-level feature extraction to mitigate issues arising from the high similarity of low-level features in noisy images. Additionally, a Real-Coded Genetic Algorithm optimizes the parameters of Gabor filters and the network, ensuring optimal feature extraction and classification performance. Experimental results demonstrate that the proposed CDBN outperforms comparative models, achieving an F1 score of 0.9258. These results indicate that the architecture effectively overcomes the challenges of lesion classification in retinal images, offering a robust tool for clinical application and paving the way for advanced clinical decision support systems in diabetic retinopathy management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.